The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
BofA has lowered its rating of Hims & Hers (NYSE:HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and erectile dysfunction treatment markets. “Today HIMS ...
Shares of Hims & Hers (NYSE: HIMS) is down big this week after Amazon (NASDAQ: AMZN) announced its expansion into telehealth. The market thinks this is terrible news, but is it? Travis Hoium ...
Hims & Hers (NYSE:HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular weight-loss drugs are in short supply. Novo Nordisk (NVO) markets ...
Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit telehealth service, which Citi believes is “very similar ...
Investing.com -- Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a ...
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded GLP-1s on the market. The tracker allows patients to self-identify ...
Hims & Hers Health (HIMS, Financials) shares slumped 24.5% on Thursday as Amazon (AMZN, Financials) expanded into hair loss and erectile dysfunction treatment sectors; shares are recovering ...
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new ...
Hims & Hers' GLP-1 Supply Tracker saw nearly 7,000 reports of access issues in its first week, especially for semaglutide-based medications. Nearly 80,000 users reported issues accessing branded ...
It was reported on November 14, that DAVID WELLS, Board Member at Hims & Hers Health (NYSE:HIMS) executed a significant insider sell, according to an SEC filing. What Happened: WELLS's decision to ...